Council Post: AI: From Drug Discovery To Robotics

Steve is the Founder of AI4Diversity, an AI expert at ISO and a social media influencer. First, companies began using artificial intelligence (AI) to transform drug discovery. Now, they are jumping into the robotics race. With robots running labs, there can be more experiments performed faster and in parallel, generating high-quality data that strengthens AI's ability to make accurate hypotheses and validate those hypotheses. Ultimately, that means new drugs can get to market faster where they can start helping patients.